Does NIRSEVIMAB-ALIP Cause Respiratory syncytial virus infection? 76 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Respiratory syncytial virus infection have been filed in association with NIRSEVIMAB-ALIP. This represents 9.7% of all adverse event reports for NIRSEVIMAB-ALIP.
76
Reports of Respiratory syncytial virus infection with NIRSEVIMAB-ALIP
9.7%
of all NIRSEVIMAB-ALIP reports
2
Deaths
54
Hospitalizations
How Dangerous Is Respiratory syncytial virus infection From NIRSEVIMAB-ALIP?
Of the 76 reports, 2 (2.6%) resulted in death, 54 (71.1%) required hospitalization, and 5 (6.6%) were considered life-threatening.
Is Respiratory syncytial virus infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB-ALIP. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does NIRSEVIMAB-ALIP Cause?
Drug ineffective (173)
Respiratory syncytial virus bronchiolitis (135)
Bronchiolitis (83)
Incorrect dose administered (80)
Pyrexia (54)
Cough (45)
Respiratory syncytial virus test positive (36)
Extra dose administered (30)
Product storage error (30)
Rash (25)
What Other Drugs Cause Respiratory syncytial virus infection?
PALIVIZUMAB (1,692)
LENALIDOMIDE (355)
DUPILUMAB (261)
CYCLOPHOSPHAMIDE (201)
ADALIMUMAB (186)
PREDNISONE (186)
METHOTREXATE (182)
POMALIDOMIDE (181)
HUMAN IMMUNOGLOBULIN G (174)
TACROLIMUS (163)
Which NIRSEVIMAB-ALIP Alternatives Have Lower Respiratory syncytial virus infection Risk?
NIRSEVIMAB-ALIP vs NITAZOXANIDE
NIRSEVIMAB-ALIP vs NITISINONE
NIRSEVIMAB-ALIP vs NITRAZEPAM
NIRSEVIMAB-ALIP vs NITRENDIPINE
NIRSEVIMAB-ALIP vs NITRIC